Home › Funds › Penn Capital Management Company, LLC › KNSA

Penn Capital Management Company, LLC position in KNSA

KINIKSA PHARMACEUTICALS INTL · Health Care

Penn Capital Management Company, LLC reported holding 347,664 shares of KNSA (KINIKSA PHARMACEUTICALS INTL) in its Q3 2026 13F filing — a position valued at US$26.0M, representing 1.92% of its reported portfolio and ranking #4 among its reported holdings. Penn Capital Management Company, LLC has disclosed KNSA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)347.66K sh
Reported value held$25.97M
Portfolio Weight1.92%
First reportedQ1 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Penn Capital Management Company, LLC's KNSA position evolved

Penn Capital Management Company, LLC first disclosed a stake in KNSA in Q1 2026 at 301,993 shares (US$14.6M). The position peaked in Q3 2026 at 347,664 shares, worth US$26.0M. Across 3 filings, Penn Capital Management Company, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 347,664 shares valued at US$26.0M — a reduction of -20,450 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 301.99K $14.56M New
Q2 2026 368.11K $23.57M Add
Q3 2026 347.66K $25.97M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KNSA and 13F data

KNSA (KINIKSA PHARMACEUTICALS INTL) is a Health Care company. 50 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KNSA

All KNSA fund holders →

FAQ

How long has Penn Capital Management Company, LLC held KNSA?

Penn Capital Management Company, LLC has disclosed KNSA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Penn Capital Management Company, LLC's current position in KNSA?

As of Q3 2026, Penn Capital Management Company, LLC holds 347.66K shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $25.97M, representing 1.92% of its reported portfolio and ranking #4.

Has Penn Capital Management Company, LLC been buying or selling KNSA?

In the latest 13F filing (Q3 2026), Penn Capital Management Company, LLC reduced its position in KNSA. The position peaked in Q3 2026 at 347.66K shares.

Which other funds hold KNSA?

Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.